Ellen ‘t Hoen | Medicines Law & Policy | Page 2

20 POSTS 0 COMMENTS

http://medicineslawandpolicy.org

Medicines Excitement in the Netherlands – New Health Minister announces firm action on...

Ellen 't Hoen - November 24, 2017

Pharmaceutical Pricing Hostages

Ellen 't Hoen - September 13, 2017

Dolutegravir Patent Licences Can Provide Access To All

Ellen 't Hoen - July 26, 2017

The Most Common Misunderstanding about Compulsory Licensing

Ellen 't Hoen - May 25, 2017

The Italian Exception – A personalised approach to accessing high-priced patented medicines

Ellen 't Hoen - May 5, 2017

Access to medicines amendment of the WTO TRIPS Agreement. Hype or hope?

Ellen 't Hoen - April 11, 2017

UN High-Level Panel on Access to Medicines calls for stronger public leadership in innovation...

Ellen 't Hoen - September 15, 2016

High medicines prices in Europe – do not Brexit the people

Ellen 't Hoen - July 21, 2016

Gilead’s sofosbuvir patent in India – options for global access to new hepatitis C...

Ellen 't Hoen - May 26, 2016

Why The Request By Least Developed Countries For An Extension Of The Transitional Period...

Ellen 't Hoen - February 27, 2015

12Page 2 of 2